Skip to main content
Terug
Watch Compare

Revium Rx.

Datakwaliteit: 67%
RVRC
OTC Manufacturing Chemicals
€ 1,67
€ 0,00 (0,00%)
Marktkapitalisatie: 101,42 M
Prijs
€ 1,67
Marktkapitalisatie
101,42 M
Dagbereik
52-Weeksbereik
Volume
Openen —
50D / 200D Gem.
50D / 200D Gem.

Quick Summary

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-195,45%
Onder sectorgemiddelde (-53,34%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio2,26
Interest CoverageN/A

Waardering

PE (TTM)
-7,54
Onder sectorgemiddelde (-1,47)
P/B Ratio14,74
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -7,5 -1,5
P/B 14,7 1,6
ROE % -195,5 -53,3
Net Margin % -41,5
Rev Growth 5Y % 1,8
D/E 0,3

ETFs Holding This Stock

AVDS logo AVDS Avantis International Small Cap Equity ETF
0,02% weight
AVSD logo AVSD Avantis Responsible International Equity ETF
0,01% weight
AVDNX AVDNX
0,00% weight
AVDV logo AVDV Avantis International Small Cap Value ETF
0,00% weight
AVDVX AVDVX
0,00% weight
AVANX AVANX
0,00% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -13,45 M
ROE -195,45% ROA -162,11%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,26
Interest Coverage N/A Asset Turnover N/A
Working Capital 1,73 M Tangible Book Value 1,81 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7,54 Forward P/E N/A
P/B Ratio 14,74 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield N/A
Market Cap 101,42 M Enterprise Value 99,74 M
Per Share
EPS (Diluted TTM) -0,22 Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue
Net Income -13,45 M
EPS (Diluted) -0,22
Gross Profit
Operating Income
EBITDA
R&D Expenses
SG&A Expenses
D&A
Interest Expense
Income Tax 358.000,0

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 8,30 M
Total Liabilities 1,42 M
Shareholders' Equity 6,88 M
Total Debt
Cash & Equivalents 1,68 M
Current Assets 3,10 M
Current Liabilities 1,37 M